Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 16 , ISSUE 4 ( July-August, 2024 ) > List of Articles

Original Article

Intrauterine Insemination vs Timed Intercourse in Letrozole and FSH-stimulated Cycles in Dysovulatory Infertility

Anu Pathak, Vikansha Kaushik

Keywords : Extended letrozole protocol, Human menopausal gonadotropin, Infertility, Intrauterine insemination, Ovulation induction letrozole, Timed intercourse

Citation Information : Pathak A, Kaushik V. Intrauterine Insemination vs Timed Intercourse in Letrozole and FSH-stimulated Cycles in Dysovulatory Infertility. J South Asian Feder Obs Gynae 2024; 16 (4):365-368.

DOI: 10.5005/jp-journals-10006-2445

License: CC BY-NC 4.0

Published Online: 09-07-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Background: Dysovulatory infertility is a major cause of infertility. It is treated with ovulation induction complemented with an assisted reproductive technique such as intrauterine insemination (IUI) and timed intercourse (TI). The data to compare the efficacy of IUI vs TI in super-ovulated cycles is limited. Aim: Comparison of pregnancy rates following IUI vs TI in letrozole and follicle-stimulating hormone (FSH) cycles in dysovulatory infertility. Method: Following the history and examination of subjects enrolled, baseline hormonal levels were done on day 2, transvaginal ultrasonography (TVS) for number and size of follicles and endometrial thickness was done on days 8, 10, and 12, and ultrasonography (USG) to confirm ovulation was done on day 14, if confirmed, it was followed by IUI or TI. Urine pregnancy test (UPT) at 2 weeks established successful conception. Those not conceiving received another cycle, to a maximum of 3 cycles. Result: A total of 120 subjects received 320 cycles. Intrauterine insemination shows better conception rates than TI (p-value < 0.05). The clinical pregnancy rate for the IUI group is 18.5% (28 in 154 cycles) and 10% (16 in 166) in the TI group. The success rate is positively correlated with younger age of patients, better educational status, and higher socioeconomic status. Conclusion: Intrauterine insemination combined with letrozole and FSH-stimulated dysovulatory infertility is an effective method to improve pregnancy outcomes.


HTML PDF Share
  1. WHO. Infertility. Available from: https://www.who.int/health-topics/infertility#tab=tab_1.
  2. Population Council. Infertility Looking back, looking forward: A profile of sexual and reproductive health in India. New Delhi: Population Council. 2004. pp. 67–72.
  3. World Health Organization. Infecundity, infertility, and childlessness in developing countries. DHS Comparative Reports No 9. Calverton, Maryland, USA: ORC Macro and the World Health Organization; 2004. Available from: https://www.who.int/publications/m/item/infecundity-infertility-and-childlessness-in-developing- countries---dhs-comparative-reports-no.-9.
  4. Vardhan S, Yadav P, Agarwal R, et al. Effect of sildenafil citrate and estradiol valerate on endometrial characteristics in ovulation-induced cycle in women with dysovulatory infertility. J South Asian Feder Obs Gynae 2019;11(3):164–166. DOI: 10.5005/jp-journals-10006-1687.
  5. Collins JA, Wrixon W, Janes LB, et al. Treatment-independent pregnancy among infertile couples. N Engl J Med 1983;309(20): 1201–1206. DOI: 10.1056/NEJM198311173092001.
  6. Snick HK, Collins JA, Evers JL. What is the most valid comparison treatment in trials of intrauterine insemination, timed or uninfluenced intercourse? A systematic review and meta-analysis of indirect evidence. Hum Reprod 2008;23(10):2239–2245. DOI: 10.1093/humrep/den214.
  7. Noriega-Portella L, Noriega-Hoces L, Delgado A, et al. Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination. Fertil Steril 2008;90(5):1818–1825. DOI: 10.1016/j.fertnstert.2007.08.060.
  8. Holzer H, Casper R, Tulandi T. A new era in ovulation induction. Fertil Steril 2006;85(2):277–284. DOI: 10.1016/j.fertnstert.2005.05.078.
  9. Kolb B, Frederick J, Miller C, et al. Does a reduced HCG trigger dose compromise outcomes in a large prospective trial of vaginal progesterone for luteal phase support? Fertility and Sterility 2015;103(2):E28. DOI: 10.1016/j.fertnstert.2014.12.050.
  10. Hembram M, Biswas R, Jain A. A study of controlled ovarian stimulation with clomiphene citrate or letrozole in combination with gonadotropins and IUI in unexplained infertility. J Hum Reprod Sci 2017;10(3):173–177. DOI: 10.4103/jhrs.JHRS_120_16.
  11. Oğlak S, Sakar M, Ege S, et al. Comparison of the efficacy of letrozole and gonadotropin combination versus gonadotropin alone in intrauterine insemination cycles in patients with unexplained infertility. East J Med 2020;25(3):427–433. DOI: 10.5505/ejm.2020.24993.
  12. Jain S, Dahiya P, Yadav J, et al. A comparative study of efficacy of letrozole and clomiphene citrate for ovulation induction. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 2018;7(10):4133–4138. DOI: 10.18203/2320-1770.ijrcog20184141.
  13. Legro RS, Brzyski RG, Diamond MP, et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med 2014; 371:119.
  14. Zeyneloglu HB, Arici A, Olive DL, et al. Comparison of intrauterine insemination with timed intercourse insuperovulated cycles with gonadotropins: A meta-analysis. Fertil Steril 1998;69(3):486–491.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.